1 active not recruiting. .
Follow OSCC: new trials by email Literature Review of OSCC trials Research Report on OSCC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma Ivonescimab（AK112，a PD-1/VEGF bispecific antibody） - HNSCC, OSCC | Active not recruiting | Zhujiang Hospital | 20 | 2026-01-26 | 2026-10-27 |
Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
China (1)